Condition: Psoriasis · Atopic Dermatitis · Sponsor: BioMimetix JV, LLC
This is a randomized, placebo-controlled Phase 2 trial consisting of up to 300 subjects with either psoriasis or atopic dermatitis. In this trial BMX-010 will be topically applied twice daily for up to 28 days.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Encino Research Center | Encino, California, United States | — |
| Apex Dermatology | Denver, Colorado, United States | — |
| Colorado Skin Care | Englewood, Colorado, United States | — |
| AboutSkin Dermatology & DermSurgery | Greenwood Village, Colorado, United States | — |
| Ciocca Dermatology | Miami, Florida, United States | — |
| Dawes Fretzin Dermatology Group | Indianapolis, Indiana, United States | — |
| Juva Skin & Laser Center | New York, New York, United States | — |
| Coastal Carolina Research Center | Mt. Pleasant, South Carolina, United States | — |
| Dermatology Associates of Nashville | Knoxville, Tennessee, United States | — |
| Presicion Research Institute | Houston, Texas, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03381625